176 related articles for article (PubMed ID: 28566070)
1. Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative.
Chalasani S; Peiris DP; Usherwood T; Redfern J; Neal BC; Sullivan DR; Colagiuri S; Zwar NA; Li Q; Patel A
Med J Aust; 2017 Jun; 206(10):436-441. PubMed ID: 28566070
[TBL] [Abstract][Full Text] [Related]
2. An electronic decision support-based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE).
Webster R; Usherwood T; Joshi R; Saini B; Armour C; Critchley S; Di Tanna GL; Galgey S; Hespe CM; Jan S; Karia A; Kaur B; Krass I; Laba TL; Li Q; Lo S; Peiris DP; Reid C; Rodgers A; Shiel L; Strathdee J; Zamora N; Patel A
Med J Aust; 2021 May; 214(9):420-427. PubMed ID: 33899216
[TBL] [Abstract][Full Text] [Related]
3. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial.
Peiris D; Usherwood T; Panaretto K; Harris M; Hunt J; Redfern J; Zwar N; Colagiuri S; Hayman N; Lo S; Patel B; Lyford M; MacMahon S; Neal B; Sullivan D; Cass A; Jackson R; Patel A
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):87-95. PubMed ID: 25587090
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
5. Value of a facilitated quality improvement initiative on cardiovascular disease risk: findings from an evaluation of the Aggressively Treating Global Cardiometabolic Risk Factors to Reduce Cardiovascular Events (AT GOAL).
Losby JL; Osuji TA; House MJ; Davis R; Boyce SP; Greenberg MC; Whitehill JM
J Eval Clin Pract; 2015 Oct; 21(5):963-70. PubMed ID: 26223497
[TBL] [Abstract][Full Text] [Related]
6. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
7. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
8. QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care.
Redfern J; Hafiz N; Hyun K; Knight A; Hespe C; Chow CK; Briffa T; Gallagher R; Reid C; Hare DL; Zwar N; Woodward M; Jan S; Atkins ER; Laba TL; Halcomb E; Billot L; Johnson T; Usherwood T
BMC Fam Pract; 2020 Feb; 21(1):36. PubMed ID: 32059641
[TBL] [Abstract][Full Text] [Related]
9. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
10. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.
Wong ND; Patao C; Wong K; Malik S; Franklin SS; Iloeje U
Diab Vasc Dis Res; 2013 Nov; 10(6):505-13. PubMed ID: 23975724
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sustained Use of a Multifaceted Computerized Quality Improvement Intervention for Cardiovascular Disease Management in Australian Primary Health Care.
Patel B; Peiris D; Usherwood T; Li Q; Harris M; Panaretto K; Zwar N; Patel A
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066447
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
Shi X; He J; Lin M; Liu C; Yan B; Song H; Wang C; Xiao F; Huang P; Wang L; Li Z; Huang Y; Zhang M; Chen CS; Obst K; Li W; Yang S; Yao G; Li X
Am Heart J; 2021 Aug; 238():45-58. PubMed ID: 33957103
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
[TBL] [Abstract][Full Text] [Related]
14. Gaps in cardiovascular disease risk management in Australian general practice.
Webster RJ; Heeley EL; Peiris DP; Bayram C; Cass A; Patel AA
Med J Aust; 2009 Sep; 191(6):324-9. PubMed ID: 19769555
[TBL] [Abstract][Full Text] [Related]
15. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
[TBL] [Abstract][Full Text] [Related]
16. A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
Patel B; Peiris DP; Patel A; Jan S; Harris MF; Usherwood T; Panaretto K; Lung T
Med J Aust; 2020 Jul; 213(2):73-78. PubMed ID: 32594567
[TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
Tsuyuki RT; Al Hamarneh YN; Jones CA; Hemmelgarn BR
J Am Coll Cardiol; 2016 Jun; 67(24):2846-54. PubMed ID: 27058907
[TBL] [Abstract][Full Text] [Related]
18. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
Sinclair G; Kerr A
N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
[TBL] [Abstract][Full Text] [Related]
19. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
20. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
Ferrario CM; Joyner J; Colby C; Exuzides A; Moore M; Simmons D; Bestermann W; Frech-Tamas F
Vasc Health Risk Manag; 2013; 9():391-400. PubMed ID: 23901282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
